Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis (Q77930168)
Jump to navigation
Jump to search
scientific article published on 01 April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis |
scientific article published on 01 April 2002 |
Statements
Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis (English)
William J Shergy
Reuben A Isern
David A Cooley
John L Harshbarger
J Eugene Huffstutter
Gordon M Hughes
Elizabeth A Spencer-Smith
Allan L Goldman
Sanford H Roth
J Scott Toder
Diana Warner
Adrienne Quinn
Gregory F Keenan
Thomas F Schaible
PROMPT Study Group. Profiling Remicade Onset with MTX in a Prospective Trial